Supporting this argument, Chanda et al. [51] demonstrated that BAL-derived mesenchymal stromal cells from progressive IPF patients have reduced FGF-10 expression compared to cells from stable IPF patients, suggesting that, in an advanced disease stage, LR-MSC have lost the potential to regenerate the damaged epithelium. This evidence concerns the gene FGF10 and idiopathic pulmonary fibrosis.